Electrocardiographic abnormalities to the patients infected with HIV/AIDS under antiretroviral tritherapy at the University Clinics of Kinshasa

Author:

Masikini Benjamin Lupenzi1,kisoka christian1,Longo-Mbenza Benjamin1

Affiliation:

1. Department of Internal Medicine, University clinics of Kinshasa, University of Kinshasa

Abstract

Abstract Introduction: Electrocardiogram (ECG) abnormalities are common to HIV-infected patients on antiretroviral therapy (ART). However, the relationship between ART, cardiovascular risk and cardiac electrical activity to patients living with HIV (PLWHIV) remains poorly studied in Kinshasa. The objective of this study was to describe the impact of tritherapy on the electrocardiogram of HIV-infected patients. Methods: This was a retrospective, descriptive, evaluative cohort with secondary analysis of a clinical cases serie of 155 HIV-infected patients under ART in the internal medicine department of University hospitals of Kinshasa (UHK) from 2013 to 2020. Results: The mean age of the patients was 54±11 years, with extremes ranging from 16 to 80 years, a sex ratio M/F=1. The dominant comorbidities were High blood pressure (HBP) at 23.4% and Pulmonary tuberculosis at 18. 8%. Dyspnea, HBP and lower limb edema were the main complaints, respectively 29.9%, 22.7% and 20.1%. The majority of patients were treated with TDF+3TC+EFV at 86.4% and a small proportion at 13.6% for TDF+3TC+ LPV/r. A total of 83.1% or 128 HIV-infected patients showed cardiac abnormalities on ECG. These were dominated by Left Ventricular Hypertrophy (LVH) 37%, sinus tachycardia 35% and repolarization disorders (subepicardial ischemia, subendocardial ischemia) 16.2%. With the TDF+3TC+LPV/r regimen, cardiac ECG abnormalities were more observed than with the TDF+3TC+EFV regimen with P<0.05; Right Ventricular Hypertrophy (RHV) at 40.4% with TDF+3TC+LPV/r regimen versus 4.7% with TDF+3TC+EFV P<0.001; myocardial ischaemia observed at 28.3% versus 11.2% with TDF+3TC+EFV regimen P=0.020. Conclusion: Electrocardiographic abnormalities are frequent and polymorphic to PLWHIV under ART (83.1%), often aggravated by protease inhibitors. The ECG should be used as a tool to screen for these abnormalities before and after 6 months of ART initiation.

Publisher

Research Square Platform LLC

Reference24 articles.

1. Combination antiretroviral therapy and the risk of myocardial infarction;Friis-Møller N;N Engl J Med,2003

2. HIV and Antiretroviral Therapy Are Independently Associated with Cardiometabolic Variables and Cardiac Electrical Activity in Adults from the Western Cape Region of South Africa;Williams C;J Clin Med,2021

3. HIV and Heart Disease: What Cardiologists Should Know;Boccara F;Rev Esp Cardiol Engl Ed,2016

4. Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure;Alvi RM;J Am Coll Cardiol,2018

5. (1997: WHO Consultation on Obesity, Geneva S. World Health Organization.Obesity: prevention and management of the global epidemic: report of a WHO consultation. Obes Prev Manag Glob Epidemic Rep WHO Consult. 2003. https://apps.who.int/iris/handle/10665/42734.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3